Addendum to: Nature Communications ; https://doi.org/10.1038/s41467-018-04994-z; published online 2 July 2018

Information relating to the in vivo treatments with A-196 and E-616452 was inadvertently omitted from the Methods section of this Article. In Fig. 6, Supplementary Fig. 7, as well as Supplementary Table 1, A-196 and E-616452 were used at a concentration of 25 mg/kg. A-196 and E-616452 were diluted in DMSO to a final concentration of 100 mM. Mice were treated with the inhibitors daily by oral gavage for 1 month.